Related Experiment Video
Updated: May 31, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Erectile function rehabilitation after radical prostatectomy: practice patterns among AUA members
Raanan Tal1, Patrick Teloken, John P Mulhall
1Sexual and Reproductive Medicine Program, Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
The Journal of Sexual Medicine
|June 18, 2011
Summary
Penile rehabilitation is common after radical prostatectomy, with most urologists recommending it. Phosphodiesterase type 5 inhibitors are the preferred treatment for erectile function recovery.
Area of Science:
- Urology
- Sexual Medicine
- Oncology
Background:
- Erectile function (EF) rehabilitation after radical prostatectomy (RP) lacks established guidelines.
- Evidence supports the benefits of post-RP EF rehabilitation.
Purpose of the Study:
- To investigate the current practice patterns of erectile function rehabilitation among American Urological Association (AUA) urologists.
- To identify factors influencing the adoption of rehabilitation strategies.
Main Methods:
- A 35-question survey was distributed to AUA members.
- The survey assessed physician demographics, training, and post-RP rehabilitation practices.
- Data were collected and analyzed by the investigators.
Main Results:
- 86% of surveyed urologists recommended rehabilitation practices post-RP.
- Urologic oncologists and RP surgeons were more likely to employ rehabilitation.
- Phosphodiesterase type 5 inhibitors (PDE5i) were the primary strategy, with 87% preference, followed by vacuum erection devices (VED), intracavernosal injections (ICI), and urethral suppositories.
Conclusions:
- Penile rehabilitation is a widespread practice among surveyed urologists.
- Specialization in urologic oncology or performance of RP correlates with higher rates of rehabilitation use.
- Consistent use of PDE5 inhibitors for 12-18 months is the most frequent rehabilitation approach.
